e-journal

Long-Term Citrate Anticoagulation in Chronic Hemodialysis Patients

---

Abstract:
In some cases, long-term (>3 months) citrate anticoagulation is needed in maintenance hemodialysis patients due to a persistent bleeding risk. In this retrospective observational study, we present our experience and assess its safety and effects on mineral and bone disorder parameters. Sixteen patients (mean age 67  15 years) were treated with long-term citrate anticoagulation. The indications were: recurrent gastrointestinal bleeding in
nine patients, heparin-induced thrombocytopenia, retroperitoneal hematoma, chronic subdural hematoma, proliferative diabetic retinopathy, vascular malformations in the brain in one patient, and others in two patients. Metabolic complications and intact parathyroid hormone (iPTH) were analyzed. Citrate anticoagulation was performed for 4 months to 6.3 years (median 12 months). Ionized calcium was stable during the procedures; hypocalcemia
(

---

Ketersediaan

Tidak ada salinan data

Informasi Detail

Judul Seri

Therapeutic Apheresis and Dialysis

No. Panggil

-

Penerbit

: Therapeutic Apheresis and Dialysis., 2011

Deskripsi Fisik

Therapeutic Apheresis and Dialysis 15(3):278–282

Bahasa

English

ISBN/ISSN

doi: 10.1111/j.1744-

Klasifikasi

-

Tipe Isi

-

Tipe Media

-

Tipe Pembawa

-

Edisi

15(3):, 2011

Subjek

Therapeutic Apheresis and Dialysis

Info Detail Spesifik

-

Pernyataan Tanggungjawab

deliza

Versi lain/terkait

Lampiran Berkas

Komentar

---

Anda harus masuk sebelum memberikan komentar